Table 1 Proteins and antibodies used in the study

From: Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays

Protein

Clone

Source

Detection

Reactivity

Threshold (1/2)

Internal control

RING17, 42

RABBIT-Pc

MV

LSAB/DAB

0, 1, 2

25/50% cells

Reactive lymphocytes, endothelial cells

RNF242, 48

Mc (3-α)

HK

LSAB/DAB

0, 1, 2

25/50% cells

Reactive lymphocytes, endothelial cells

BMI142

GOAT-Pc (C20)

SC

ENVIS/DAB

0, 1, 2

25/50% cells

Reactive lymphocytes, endothelial cells

MEL1829, 42

GOAT-Pc (C20)

SC

LSAB/DAB

0, 1, 2

25/50% cells

Reactive lymphocytes, plasma cells

RYBP8, 42

RABBIT-Pc

MV

LSAB/DAB

0, 1, 2

10/25% cells

TMA controls (placenta)

HPH142, 56

Mc (α)

HK

LSAB/DAB

0, 1, 2

10/25% cells

TMA controls (germinal cells in testis)

KI67

MIB1-Mc

DAKO

ENVIS/DAB

0, 1, 2

25/50% cells

Proliferating cells

  1. Source, detection, reactivity, threshold and controls are indicated.
  2. SC, Santa Cruz Biotechnology Inc. (CA, USA); HK, produced by H Koseki; MV, produced by M Vidal; Pc, polyclonal; Mc, monoclonal; DAB, diaminobenzidine; LSAB, LSAB Visualization System (DAKO, Glostrup, Denmark); TMA, tissue microarray.
  3. For HPH1 and RYBP, 1: 10–25% positive cells; 2: more than 25% positive cells.
  4. For all others, 1: 25–50% positive cells; 2: more than 50% positive cells.